BG Medicine Inc (BGMD.OQ)

BGMD.OQ

About

BG Medicine, Inc. (BG Medicine) is a life sciences company focused on the discovery, development and commercialization of cardiovascular diagnostics to addresses unmet medical needs. The Company focuses on blood-based tests. Its lead product candidate in development is CardioSCORE, which is a multi-analyte biomarker-based blood... (more)

Buy/Sell

» Analyst Consensus

Overall

Beta:	--
Market Cap (Mil.):	$43.30
Shares Outstanding (Mil.):	27.58
Dividend:	--
Yield (%):	--

Financials

	BGMD.OQ	Industry	Sector
P/E (TTM):	--	31.05	31.28
EPS (TTM):	-1.01	--	--
ROI:	-113.44	19.56	18.90
ROE:	-188.88	20.32	19.80

Latest News about BGMD.OQ

» More BGMD.OQ News

Competitors

	Price	Change
Mitsubishi Corp (8058.T)	¥1,789	+71.00
General Electric Company (GE.N)	$24.33	+0.56
Siemens AG (SIEGn.DE)	€79.99	+0.03
Roche Holding Ltd. (ROG.VX)	CHF228.90	-2.20
Abbott Laboratories (ABT.N)	$37.51	+0.62
Sanofi SA (SASY.PA)	€81.55	-1.02
Koninklijke Philips NV (PHG.AS)	€21.75	+0.04
Quest Diagnostics Inc (DGX.N)	$62.39	-0.20
Alere Inc (ALR.N)	$25.58	+0.10
Alere Inc (ALR_pb.N)	$233.75	+0.75

Earnings vs. Estimates

Analyst Research Reports

Report Title	Price
Thomson Reuters Stock Report - BG MEDICINE INC (BGMD-O) Provider: Thomson Reuters Stock Report	$25.00 Buy
BG MEDICINE INC (BGMD) 12-months forecast Provider: Pechala's Reports	$15.00 Buy
BG Medicine Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. Provider: Reuters Investment Profile	$20.00 Buy
ValuEngine Detailed Valuation Report for BGMD Provider: ValuEngine, Inc.	$127.00 Buy
Wright Investors Service Comprehensive Report for BG Medicine Inc Provider: Wright Reports	$449.00 Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

Related Topics:

Edition:

U.S.
- Arabic
- Argentina
- Brazil
- Canada
- China
- France
- Germany
- India
- Italy
- Japan
- Latin America
- Mexico
- Russia
- Spain
- United Kingdom

Back to top

Reuters.com

Legal

Support & Contact

Connect with Reuters

About

Our Flagship financial information platform incorporating Reuters Insider

An ultra-low latency infrastructure for electronic trading and data distribution

A connected approach to governance, risk and compliance

Our next generation legal research platform

Our global tax workstation

Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.

NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.